首页 › 乳腺癌 › 纽约州

纽约州的乳腺癌临床试验

纽约州有 176 项针对乳腺癌的研究正在招募参与者。

纽约州的城市

官方研究文本（英文）

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, New York
Research Site, New York

招募中1/2 期

18 至 130 岁 · 所有性别 · 更新于 2026年10月5日 · NCT05417594

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Irving Medical Center, New York
以及另外 1 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06982521

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Kings County Hopsital Center, Brooklyn
Queens Cancer Center of Queens Hospital, Jamaica
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
以及另外 1 项

招募中

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT04751435

A Study of Mental Health Care in People With Cancer

Memorial Sloan Kettering Cancer Center, New York

招募中

65 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06037954

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06784193

A Study of PHST001 in Advanced Solid Tumors

START Center for Cancer Research - Long Island New York, Lake Success
Mount Sinai, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06840886

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
以及另外 1 项

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT05534438

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Roswell Park Cancer Institute, Buffalo

招募中欢迎健康志愿者

18 岁及以上 · 女性 · 更新于 2026年10月2日 · NCT03897270

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Queens Cancer Center of Queens Hospital, Jamaica
Optum Health, Lake Success
Mount Sinai School of Medicine, New York

招募中3 期

18 至 100 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

招募中观察性研究欢迎健康志愿者

40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, New York

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07205822

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Hematology Oncology Associates of Central New York, Camillus
Memorial Sloan Kettering Cancer Center, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07102381

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07701941

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Roswell Park Comprehensive Cancer Center, Buffalo

招募中2 期

70 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT04305834

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Rochester Medical Center, Rochester

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Memorial Sloan-Kettering Cancer Center, New York
New York Cancer & Blood Specialists, Shirley

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06324357

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
以及另外 1 项

招募中

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07218250

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

New York Proton Center, New York

招募中2 期

50 岁及以上 · 女性 · 更新于 2026年9月29日 · NCT01766297

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT05877599

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

New York Proton Center, New York

招募中3 期

19 岁及以上 · 女性 · 更新于 2026年9月29日 · NCT05856773

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Queens Hospital Cancer Center ( Site 0011), Jamaica
Optum Medical Care, PC ( Site 0009), Westbury

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NYU Langone Health - Brooklyn ( Site 0089), Brooklyn
NYU Langone Hospital - Long Island ( Site 0090), Mineola
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
以及另外 2 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New York
Research Site, Stony Brook

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Memorial Sloan Kettering Cancer Center, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07007559

A Study of Language Interpretation Solutions for People With Breast Cancer

Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), Harrison
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
以及另外 2 项

招募中

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
以及另外 1 项

招募中1 期

18 岁及以上 · 女性 · 更新于 2026年9月24日 · NCT05412225